A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma

Abstract

MRI of the spine and pelvis still remains the gold standard imaging technique for the detection of bone marrow involvement in MM. 18F-FDG PET-CT provides additional and valuable information for the assessment of myeloma bone disease in areas not covered by MRI.

References

Page 1

	Year	Citations
A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Brian G.M. Durie, Sydney E. Salmon Cancer	1975	3K
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group British Journal of Haematology Hematological MalignancyMonoclonal GammopathiesAutoimmune DiseaseBone Marrow FailureMonoclonal Gammopathy	2003	2.3K
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION Joan Bladé, Diana Samson, Donna Reece, British Journal of Haematology	1998	1.5K
Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma Michel Attal, Thierry Façon, François Guilhot, New England Journal of Medicine	2003	973
Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma New England Journal of Medicine Cell TherapyPathologySalivary GlandOncologySurgical Pathology	2004	817
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma Michèle Cavo, Elena Zamagni, Patrizia Tosi, Blood	2005	365
Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. Einat Even‐Sapir PubMed Early Bone InvolvementEngineeringOncologic ImagingPet-mriOsteoporosis	2005	346
Whole-body (18)F-FDG PET identifies high-risk myeloma. Brian G.M. Durie, Alan D. Waxman, Allesandro D'Agnolo, PubMed	2002	276
Value of FDG PET in the Assessment of Patients with Multiple Myeloma Miriam A. Bredella, Lynne S. Steinbach, Gary R. Caputo, American Journal of Roentgenology	2005	262
Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease. Lia A. Moulopoulos, Datla G. K. Varma, Meletios Α. Dimopoulos, Radiology PathologyMarrow InvolvementSpinal DisorderHematological MalignancyHematology	1992	180

Page 1